Metraipolis › archive › dc_bb8abef18dff

Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma — Europe PMC PMID:42630714

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42630714
DOI: 10.32604/or.2026.082815
License (as archived): solo-consultazione
Archived: 2026-10-08T06:35:10.353Z
SHA-256 of the archived text: cc43665f9215b0a1a9cf76ba24959c7cb46878ab283358690ed1bb21bf6614eb
Stable URL of this page: https://metraipolis.com/documento/dc_bb8abef18dff

How to cite

Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma — Europe PMC PMID:42630714 — Europe PMC (en), https://europepmc.org/article/MED/42630714 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bb8abef18dff (Metraipolis archive dc_bb8abef18dff, sha256 cc43665f9215b0a1a9cf76ba24959c7cb46878ab283358690ed1bb21bf6614eb)

BibTeX

@misc{dcbb8abef18dff,
  title = {Invariant Natural Killer T Cell Therapy Attenuates Systemic Inflammation and Improves Transarterial Chemoembolization Outcomes in Hepatocellular Carcinoma — Europe PMC PMID:42630714},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42630714},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bb8abef18dff; sha256 cc43665f9215b0a1a9cf76ba24959c7cb46878ab283358690ed1bb21bf6614eb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42630714. Agents can read the archived copy with the MCP tool read_document.